系统性硬化症与小肠受累:诊断方法及现有证据的系统综述
本系统综述纳入24项研究,评估系统性硬化症(SSc)患者小肠受累的诊断方法与证据。测压研究显示小肠动力异常高发,全肠道闪烁显像与死亡率增加相关(HR 4.57;95%CI:1.58-13.24)。组织病理学发现平滑肌萎缩、肠神经病变和血管纤维化参与发病。
要点
- SSc小肠受累常见,测压显示收缩幅度降低和传输延迟。
- 全肠道闪烁显像与死亡率增加相关(HR 4.57;95%CI:1.58-13.24)。
- 食管与小肠测压异常无相关性(5项研究)。
核心结论
- SSc中小肠受累常见,与收缩幅度降低和传输时间延迟相关。
- 迫切需要标准化诊断方法以实现早期识别和指导管理。
研究设计与样本
- 系统检索PubMed和Embase,纳入24项使用客观检测和患者组织评估SSc小肠受累的研究。
- 因研究设计、干预和结局异质性大,进行定性综合。
主要发现
- 测压研究显示III期复合波缺失或受损中位数50.3%(IQR 22.5%-81%),III期迁移速度降低31.3%(IQR 18%-53%),收缩幅度降低中位数62.5%(IQR 40%-75%),餐后反应异常中位数60.6%(IQR 50%-90%)。
- 5项测压研究未发现食管与小肠受累之间存在相关性。
- 全肠道闪烁显像识别出与死亡率增加强烈相关(HR 4.57;95%CI:1.58-13.24)。
- 组织病理学发现平滑肌萎缩、肠神经病变和血管纤维化参与小肠受累发病机制。
关键数值与推荐
- 9项研究(37.5%)使用测压评估小肠动力功能。
- 12项研究(50%)采用其他客观诊断方法。
- 7项研究(29.2%)报告组织病理学发现。
临床怎么用
- 对SSc患者应关注小肠受累可能,测压和全肠道闪烁显像可提供预后信息。
- 全肠道闪烁显像显示与死亡率增加相关,可用于风险分层。
局限性
- 研究设计、干预和结局异质性大,仅能进行定性综合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small bowel involvement represents a common and clinically significant manifestation of systemic sclerosis (SSc). Pathogenesis is multifactorial, and diagnosis remains challenging due to non-specific symptoms, limited diagnostic tools, and a lack of standardized management strategies. METHODS: A systematic search of PubMed and Embase was conducted to identify studies evaluating small bowel involvement in patients with SSc using objective tests and patient tissue. A qualitative synthesis was performed due to the anticipated heterogeneity in study designs, interventions, and outcomes. RESULTS: Of the 24 studies included, 9 (37.5%) evaluated small bowel motor function using manometry, 12 (50%) employed other objective diagnostic methods, and 7 (29.2%) reported histopathological findings. Manometric studies showed a high prevalence of motor abnormalities: absent or impaired phase III complexes (median 50.3%, IQR,22.5%-81%), reduced phase III migration velocity (31.3%, IQR,18%-53%), diminished contraction amplitude (median 62.5%, IQR,40%-75%), and abnormal postprandial responses (median 60.6%, IQR,50%-90%). No correlation was found between esophageal and small bowel involvement when both were assessed by manometry(5 studies). Transit studies (breath tests, capsule endoscopy, and whole-gut scintigraphy) showed variable performance; however, whole-gut scintigraphy identified clinically relevant associations, including a strong link with increased mortality (HR 4.57; 95% CI: 1.58-13.24). Histopathological results identified smooth muscle atrophy, enteric neuropathy, and vascular fibrosis in the pathogenesis of small bowel involvement. CONCLUSIONS: In SSc, small bowel involvement is frequent and associated with decreased contractile amplitude and delayed transit time. There is a critical need for standardized diagnostic approaches to enable early recognition and guide management.
引用
- Alcala-Gonzalez LG, Felix-Tellez FA, Ayla AY, et al. Systemic sclerosis and small bowel involvement: A systematic review of diagnostic approaches and current evidence. Semin Arthritis Rheum. 2026. PMID: 41996926. doi:10.1016/j.semarthrit.2026.152978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。